Skip to main content

Table 1 List of participating study centers

From: Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis

#

Site/address

01

Jena University Hospital, Department of Neurology

Am Klinikum 1, 07747 Jena, Germany

02

University Hospital Schleswig-Holstein Campus Kiel, Neuroimmunology, Department of Neurology and Inst. of Clinical Chemistry

Arnold-Heller-Str. 3, Haus 41, 24105 Kiel, Germany

03

University Hospital Ulm, Department of Neurology

Oberer Eselsberg 45, 89081 Ulm, Germany

04

Charité – University Medicine Berlin, Department of Neurology

Charitéplatz 1, 10117 Berlin, Germany

05

University Hospital Münster, Department of Neurology

Albert-Schweitzer-Campus 1, 48149 Münster, Germany

06

University Hospital Würzburg, Department of Neurology

Josef-Schneider-Straße 11, 97080 Würzburg, Germany

07

Medizinische Hochschule Hannover, Department of Neurology

Carl-Beuberg-Str. 1, 30625 Hannover, Germany

08

Ludwig-Maximilians-University Munich, Institute of Clinical Neuroimmunology and Department of Neurology

Marchioninistraße 15, 81377 München, Germany

09

Ruhr-University Bochum, St. Josef Hospital, Department of Neurology

Gudrunstr. 56, 44791 Bochum, Germany